Source - LSE Regulatory
RNS Number : 1379V
Assura PLC
30 November 2023


30 November 2023

Assura plc


Notice of Dividend


Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that the next quarterly interim dividend of 0.82 pence per share will be paid on 10 January 2024 to shareholders on the register on 8 December 2023 (the "Record Date"). The Ex-dividend Date will be 7 December 2023.


This interim dividend will be a normal dividend (non-PID). Please refer to Company's website HERE for more information.


Shareholders may choose for the dividend to be paid either as cash or to be settled in New Shares via the Scrip Dividend Alternative. The Scrip Dividend Alternative price is to be calculated using the average of the middle market quotations for an Ordinary Share, as derived from the Daily Official List of the London Stock Exchange, for the five consecutive business days commencing on the Ex-dividend Date and will be announced by the Company and detailed on the Company's website on 14 December 2023.


Any shareholders wishing to take up the Scrip Dividend Alternative, who have not already done so, will have until 4.30pm on 28 December 2023 either to return their completed mandate form to the Company registrars, Link Group at 10th Floor, Central Square, 29 Wellington Street, Leeds, LS1 4DL (in the case of shareholdings in certificated form) or to take the necessary action via the CREST system (in the case of shareholdings in uncertificated form).


The Circular concerning this Scrip Dividend Alternative is available on the Company's website, and is also available for inspection at the National Storage Mechanism


- Ends -


For more information, please contact:


Assura plc
David Purcell, Investor Relations Director

Tel: 0161 515 2043


FGS Global

Gordon Simpson


Tel: 0207 251 3801



 Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.


A constituent of the FTSE 250 and the EPRA* indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.


At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 


Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.


Further information is available at


*EPRA is a registered trademark of the European Public Real Estate Association.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJBell logo

Related Charts

Assura PLC (AGR)

-0.30p (-0.71%)
delayed 18:04PM